The current valuation score of Achieve Life Sciences Inc is 6.69, ranking 300 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.93, which is -87.38% below the recent high of -0.62 and -13.02% above the recent low of -5.58.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.